Iron intake and body iron stores as risk factors for Barrett's esophagus: A community-based study

American Journal of Gastroenterology

Volumn 103, Issue 12, 2008, Pages 2997-3004

  Corley, Douglas A ^a,b   Kubo, Ai ^a,c   Levin, Theodore R ^a   Habel, Laurel ^a   Zhao, Wei ^a   Leighton, Patricia ^a   Rumore, Gregory ^e   Quesenberry, Charles ^a   Buffler, Patricia ^d   Block, Gladys ^d  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Department of Medicine   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; BLEEDING; CASE CONTROL STUDY; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; IRON BLOOD LEVEL; IRON INTAKE; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; UNITED STATES; ADENOCARCINOMA; ADOLESCENT; ESOPHAGUS TUMOR; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; FERRITINS; HUMANS; IRON; IRON, DIETARY; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 58149374588     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.02156.x     Document Type: Article

References (53)

1. Blot WJ, McLaughlin JK. The changing epidemiology of esophageal cancer. Semin Oncol 1999 26 (5 Suppl 15 2 8.
2. Bollschweiler E, Wolfgarten E, Gutschow C, et al. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001 92 : 549 55.
3. Corley D, Buffler P. Oesophageal and gastric cardia adenocarcinomas: Analysis of regional variation using the cancer incidence in five continents database. Int J Epidemiol 2001 30 : 1415 25.
4. Kubo A, Corley DA. Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer 2002 95 : 2096 102.
5. Sharma P, McQuaid K, Dent J, et al. A critical review of the diagnosis and management of Barrett's esophagus: The AGA Chicago Workshop. Gastroenterology 2004 127 : 310 30.
6. Chen X, Ding YW, Yang G, et al. Oxidative damage in an esophageal adenocarcinoma model with rats. Carcinogenesis 2000 21 : 257 63.
7. Chen X, Yang G, Ding WY, et al. An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload. Carcinogenesis 1999 20 : 1801 8.
8. Geier D, Hebert B, Potti A. Risk of primary non-hepatocellular malignancies in hereditary hemochromatosis. Anticancer Res 2002 22 : 3797 9.
9. Elmberg M, Hultcrantz R, Ekbom A, et al. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. Gastroenterology 2003 125 : 1733 41.
10. Petersen DR. Alcohol, iron-associated oxidative stress, and cancer. Alcohol 2005 35 : 243 9.
11. Stevens RG, Beasley RP, Blumberg BS. Iron-binding proteins and risk of cancer in Taiwan. J Natl Cancer Inst 1986 76 : 605 10.
12. Hsing AW, McLaughlin JK, Olsen JH, et al. Cancer risk following primary hemochromatosis: A population-based cohort study in Denmark. Int J Cancer 1995 60 : 160 2.
13. Fracanzani AL, Conte D, Fraquelli M, et al. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology 2001 33 : 647 51.
14. Chen X, Yang CS. Esophageal adenocarcinoma: A review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis 2001 22 : 1119 29.
15. Chen X, Mikhail SS, Ding YW, et al. Effects of vitamin E and selenium supplementation on esophageal adenocarcinogenesis in a surgical model with rats. Carcinogenesis 2000 21 : 1531 6.
16. Luo Y, Henle ES, Linn S. Oxidative damage to DNA constituents by iron-mediated fenton reactions. The deoxycytidine family. J Biol Chem 1996 271 : 21167 76.
17. Hann HW, Stahlhut MW, Hann CL. Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines. Hepatology 1990 11 : 566 9.
18. Barrett MT, Sanchez CA, Prevo LJ, et al. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet 1999 22 : 106 9.
19. Kubo A, Corley DA. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol 2004 99 : 582 8.
20. McClung JP, Marchitelli LJ, Friedl KE, et al. Prevalence of iron deficiency and iron deficiency anemia among three populations of female military personnel in the US Army. J Am Coll Nutr 2006 25 : 64 9.
21. Barton JC, Acton RT, Dawkins FW, et al. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study. Genet Test 2005 9 : 231 41.
22. Beutler E, West C. Hematologic differences between African-Americans and whites: the roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume. Blood 2005 106 : 740 5.
23. Ganji V, Hampl JS, Betts NM. Race-, gender- and age-specific differences in dietary micronutrient intakes of US children. Int J Food Sci Nutr 2003 54 : 485 90.
24. Fleming DJ, Jacques PF, Tucker KL, et al. Iron status of the free-living, elderly Framingham Heart Study cohort: An iron-replete population with a high prevalence of elevated iron stores. Am J Clin Nutr 2001 73 : 638 46.
25. Zhang ZF, Kurtz RC, Yu GP, et al. Adenocarcinomas of the esophagus and gastric cardia: The role of diet. Nutr Cancer 1997 27 : 298 309.
26. Krieger N. Overcoming the absence of socioeconomic data in medical records: Validation and application of a census-based methodology. Am J Public Health 1992 82 : 703 10.
27. Corley DA, Kubo A, Levin TR, et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 2007 133 : 34 41.
28. Rothman KJ, Greenland S. Modern epidemiology, 2nd ed Philadelphia, PA : Lippincott-Raven, 1998.
29. Block G, Hartman AM. Issues in reproducibility and validity of dietary studies. Am J Clin Nutr 1989 50 (Suppl 5 S1133 8 discussion 1231-5.
30. Block G, Hartman AM, Dresser CM, et al. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986 124 : 453 69.
31. Block G, Thompson FE, Hartman AM, et al. Comparison of two dietary questionnaires validated against multiple dietary records collected during a 1-year period. J Am Diet Assoc 1992 92 : 686 93.
32. Block G, Woods M, Potosky A, et al. Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 1990 43 : 1327 35.
33. NutritionQuest. Vol. 2007.
34. Massey AC. Microcytic anemia. Differential diagnosis and management of iron deficiency anemia. Med Clin North Am 1992 76 : 549 66.
35. Hillman RS. Iron deficiency and other hypoproliferative anemias. In : Fauci B, Isselbacher, Wilson, Martin, Kasper, Hauser, Longo, eds. Harrison's principles of internal medicine. New York : McGraw-Hill 1998 : 638 643.
36. Beutler E, Hoffbrand AV, Cook JD. Iron deficiency and overload. Hematology (Am Soc Hematol Educ Program) 2003 40 61.
37. Beutler E, Felitti V, Ho NJ, et al. Relationship of body iron stores to levels of serum ferritin, serum iron, unsaturated iron binding capacity and transferrin saturation in patients with iron storage disease. Acta Haematol 2002 107 : 145 9.
38. Mei Z, Cogswell ME, Parvanta I, et al. Hemoglobin and ferritin are currently the most efficient indicators of population response to iron interventions: An analysis of nine randomized controlled trials. J Nutr 2005 135 : 1974 80.
39. Zhao Y, Ash AS, Ellis RP, et al. Predicting pharmacy costs and other medical costs using diagnoses and drug claims. Med Care 2005 43 : 34 43.
40. Zhao Y, Ellis RP, Ash AS, et al. Measuring population health risks using inpatient diagnoses and outpatient pharmacy data. Health Serv Res 2001 36 : 180 93.
41. Hosmer DW, Lemeshow S. Applied logistic regression, 2nd ed New York : John Wiley & Sons, 2000.
42. Breslow NE, Day NE. Statistical methods in cancer research. Volume 1 - The analysis of case-control studies. Lyon, France : International Agency for Research on Cancer, 1980.
43. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research. principles and quantitative methods New York : Van Nostrand Reinhold, 1982.
44. Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med 1993 118 : 201 10.
45. Kleinbaum DG, Kupper LL, Muller KE, et al. Applied regression analysis and multivariable models Pacific Grove, CA : Brooks/Cole, 1998.
46. Preziosi P, Hercberg S, Galan P, et al. Iron status of a healthy French population: factors determining biochemical markers. Ann Nutr Metab 1994 38 : 192 202.
47. Blanck HM, Cogswell ME, Gillespie C, et al. Iron supplement use and iron status among US adults: Results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2005 82 : 1024 31.
48. Goldstein SR, Yang GY, Curtis SK, et al. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis 1997 18 : 2265 70.
49. Koop H, Bachem MG. Serum iron, ferritin, and vitamin B12 during prolonged omeprazole therapy. J Clin Gastroenterol 1992 14 : 288 92.
50. Golubov J, Flanagan P, Adams P. Inhibition of iron absorption by omeprazole in rat model. Dig Dis Sci 1991 36 : 405 8.
51. Harrison LE, Zhang ZF, Karpeh MS, et al. The role of dietary factors in the intestinal and diffuse histologic subtypes of gastric adenocarcinoma: A case-control study in the U. S. Cancer 1997 80 : 1021 8.
52. Cross AJ, Gunter MJ, Wood RJ, et al. Iron and colorectal cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study. Int J Cancer 2006 118 : 3147 52.
53. Morrison AS. Screening in chronic disease, 2nd ed New York : Oxford University Press 1992.